{"id":"drm02","safety":{"commonSideEffects":[{"rate":"null","effect":"Injection site reactions"},{"rate":"null","effect":"Fatigue"},{"rate":"null","effect":"Headache"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"DRM02 works by binding to CD40L, a protein involved in the activation of immune cells, thereby reducing inflammation and modulating the immune response.","oneSentence":"DRM02 is a monoclonal antibody that targets CD40L.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T02:35:14.136Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Plaque psoriasis"}]},"trialDetails":[{"nctId":"NCT01993446","phase":"PHASE2","title":"A Safety and Efficacy Study of DRM02 in Subjects With Rosacea","status":"COMPLETED","sponsor":"Dermira, Inc.","startDate":"2013-10","conditions":"Rosacea","enrollment":30},{"nctId":"NCT01993420","phase":"PHASE2","title":"A Safety and Efficacy of DRM02 in Subjects With Atopic Dermatitis","status":"COMPLETED","sponsor":"Dermira, Inc.","startDate":"2013-10","conditions":"Atopic Dermatitis","enrollment":21},{"nctId":"NCT01993433","phase":"PHASE2","title":"A Safety and Efficacy Study of DRM02 in Subjects With Plaque Psoriasis","status":"COMPLETED","sponsor":"Dermira, Inc.","startDate":"2013-10","conditions":"Psoriasis","enrollment":23}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"DRM02","genericName":"DRM02","companyName":"Dermira, Inc.","companyId":"dermira-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"DRM02 is a monoclonal antibody that targets CD40L. Used for Plaque psoriasis.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}